No 'Corrections And Removals' Reports For Device Enhancements, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
CDRH clarifies that 806 corrections and removals reports are not necessary for true product enhancements that do not qualify as recalls in a final guidance.
You may also be interested in...
Device Makers To FDA: Recall The Recalls Draft Guidance
The draft guidance is an attempt by FDA to reassure companies that they can make an enhancement to a marketed device without worrying that the action will be perceived as a recall. But the effort appears to have increased, rather than alleviated, industry anxieties.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.